228 related articles for article (PubMed ID: 21743491)
1. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.
Lu D; Han C; Wu T
Oncogene; 2012 Feb; 31(7):842-57. PubMed ID: 21743491
[TBL] [Abstract][Full Text] [Related]
2. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
Lu D; Han C; Wu T
Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
[TBL] [Abstract][Full Text] [Related]
3. 15d-PGJ₂ decreases PGE₂ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter.
Liu C; Chen S; Wang X; Chen Y; Tang N
Biochem Pharmacol; 2014 Oct; 91(3):337-47. PubMed ID: 25108236
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
Lim K; Han C; Dai Y; Shen M; Wu T
Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
[TBL] [Abstract][Full Text] [Related]
5. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
6. Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis.
Sasaki Y; Kamei D; Ishikawa Y; Ishii T; Uematsu S; Akira S; Murakami M; Hara S
Oncogene; 2012 Jun; 31(24):2943-52. PubMed ID: 21986945
[TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells.
Hanaka H; Pawelzik SC; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjörnsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson PJ; Kogner P; Rådmark O
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18757-62. PubMed ID: 19846775
[TBL] [Abstract][Full Text] [Related]
8. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis.
Nakanishi M; Montrose DC; Clark P; Nambiar PR; Belinsky GS; Claffey KP; Xu D; Rosenberg DW
Cancer Res; 2008 May; 68(9):3251-9. PubMed ID: 18451151
[TBL] [Abstract][Full Text] [Related]
10. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
11. Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation.
Sha W; Olesch C; Hanaka H; Rådmark O; Weigert A; Brüne B
Int J Cancer; 2013 Oct; 133(7):1578-88. PubMed ID: 23536473
[TBL] [Abstract][Full Text] [Related]
12. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
13. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
14. Expression of microsomal prostaglandin E synthase-1 in human hepatocelluar carcinoma.
Takii Y; Abiru S; Fujioka H; Nakamura M; Komori A; Ito M; Taniguchi K; Daikoku M; Meda Y; Ohata K; Yano K; Shimoda S; Yatsuhashi H; Ishibashi H; Migita K
Liver Int; 2007 Sep; 27(7):989-96. PubMed ID: 17696939
[TBL] [Abstract][Full Text] [Related]
15. Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1/NF-κB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1.
Deckmann K; Rörsch F; Geisslinger G; Grösch S
Cell Signal; 2012 Feb; 24(2):460-467. PubMed ID: 21983014
[TBL] [Abstract][Full Text] [Related]
16. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
17. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
[TBL] [Abstract][Full Text] [Related]
18. [Role of mPGES-1 in the occurrence, progression, metastasis and invasion of hepatocellular carcinoma].
Lian YE; Liu JF; Wang XJ; Zang SB; Huang AM
Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):356-61. PubMed ID: 21645444
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
Moon Y; Glasgow WC; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
[TBL] [Abstract][Full Text] [Related]
20. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]